Metraipolis › archive › dc_c29ee87565e7

Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy — Europe PMC PMID:42038028

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42038028
DOI
10.7150/jca.131494
License (as archived)
solo-consultazione
Archived
2026-11-03T16:21:41.906Z
SHA-256 of the archived text
b892a5f56b259e7ec60041169b4a469e6aa0dbf69d2651cd8eb54f40bff87a85
Stable URL of this page
https://metraipolis.com/documento/dc_c29ee87565e7

How to cite

Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy — Europe PMC PMID:42038028 — Europe PMC (en), https://europepmc.org/article/MED/42038028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c29ee87565e7 (Metraipolis archive dc_c29ee87565e7, sha256 b892a5f56b259e7ec60041169b4a469e6aa0dbf69d2651cd8eb54f40bff87a85)
BibTeX
@misc{dcc29ee87565e7,
  title = {Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy — Europe PMC PMID:42038028},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42038028},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c29ee87565e7; sha256 b892a5f56b259e7ec60041169b4a469e6aa0dbf69d2651cd8eb54f40bff87a85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42038028. Agents can read the archived copy with the MCP tool read_document.